Keren Baruch

Keren is an associate in the Corporate Practice Group in the firm’s New York office.

Areas of Practice

Keren's practice focuses on mergers, acquisitions (both buy-side and sell-side), private equity, venture and growth equity financings and other corporate transactions. Keren has advised on transactions in a wide range of industries, including software, biotechnology, life sciences, healthcare, manufacturing, retail, entertainment, technology and advertising. Keren has experience representing public and private corporations (from start-ups to billion dollar companies), private equity firms and portfolio companies of sponsor funds. Keren also advises clients on general corporate formation and governance and day-to-day legal and commercial matters.   

Pro Bono

Keren believes in providing pro bono legal services for worthy causes. Keren serves as the pro bono coordinator for the Corporate & Securities group, and has experience representing a multitude of pro bono clients on a wide-range of matters, including (but not limited to): (1) representing a mother who was a victim of domestic abuse in a litigation in family court against her husband, where Keren’s client was awarded full custody of her children; (2) representing a number of victims of domestic violence in their application for a green card, and (3) advising small businesses on corporate formation and governance matters.

Prior Experience

Prior to joining Sheppard Mullin, Keren was an associate at Willkie Farr & Gallagher LLP. While at Willkie, Keren went on a six-month secondment at Her Justice, where she represented victims of domestic violence in both civil and criminal court in Queens, Brooklyn, Manhattan and the Bronx.

Honors

"Bob Gerber Pro Bono Award," 2023

“One to Watch," Best Lawyers, 2023-2024

Articles

FDA Law Blog Posts

• "2024 Top-of-Mind Issues for Life Sciences Companies," January 25, 2024

Healthcare Law Blog Posts

• "Connecticut Follows in the Footsteps of Other Jurisdictions Requiring Registration of Pharmaceutical Representatives," October 25, 2023